Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium

Accumulation of lipofuscin bisretinoids (LBs) in the retinal pigment epithelium (RPE) is the alleged cause of retinal degeneration in genetic blinding diseases (e.g., Stargardt) and a possible etiological agent for age-related macular degeneration. Currently, there are no approved treatments for the...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 111; no. 14; pp. E1402 - E1408
Main Authors Nociari, Marcelo M, Lehmann, Guillermo L, Perez Bay, Andres E, Radu, Roxana A, Jiang, Zhichun, Goicochea, Shelby, Schreiner, Ryan, Warren, J David, Shan, Jufang, Adam de Beaumais, Ségolène, Ménand, Mickaël, Sollogoub, Matthieu, Maxfield, Frederick R, Rodriguez-Boulan, Enrique
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 08.04.2014
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Accumulation of lipofuscin bisretinoids (LBs) in the retinal pigment epithelium (RPE) is the alleged cause of retinal degeneration in genetic blinding diseases (e.g., Stargardt) and a possible etiological agent for age-related macular degeneration. Currently, there are no approved treatments for these diseases; hence, agents that efficiently remove LBs from RPE would be valuable therapeutic candidates. Here, we show that beta cyclodextrins (β-CDs) bind LBs and protect them against oxidation. Computer modeling and biochemical data are consistent with the encapsulation of the retinoid arms of LBs within the hydrophobic cavity of β-CD. Importantly, β-CD treatment reduced by 73% and 48% the LB content of RPE cell cultures and of eyecups obtained from Abca4-Rdh8 double knock-out (DKO) mice, respectively. Furthermore, intravitreal administration of β-CDs reduced significantly the content of bisretinoids in the RPE of DKO animals. Thus, our results demonstrate the effectiveness of β-CDs to complex and remove LB deposits from RPE cells and provide crucial data to develop novel prophylactic approaches for retinal disorders elicited by LBs.
Bibliography:http://dx.doi.org/10.1073/pnas.1400530111
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC3986126
Author contributions: M.M.N., G.L.L., A.E.P.B., R.A.R., M.S., F.R.M., and E.R.-B. designed research; M.M.N., G.L.L., A.E.P.B., R.A.R., Z.J., S.G., and J.S. performed research; R.S., J.D.W., S.A.d.B., M.M., M.S., and F.R.M. contributed new reagents/analytic tools; M.M.N., G.L.L., A.E.P.B., R.A.R., Z.J., F.R.M., and E.R.-B. analyzed data; and M.M.N. and E.R.-B. wrote the paper.
Edited by Janet R. Sparrow, Columbia University, New York, NY, and accepted by the Editorial Board February 27, 2014 (received for review January 14, 2014)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1400530111